OAKVILLE, ONTARIO -- (MARKET WIRE) -- May 08, 2007 -- Excel-Tech Ltd. (TSX: NRV) (“XLTEK”) a medical technology company that designs, develops and sells proprietary neurodiagnostic medical devices, today provided an update in light of new developments in the reimbursement to primary care physicians for nerve conduction testing using XLTEK’s Front-Line NeuroPATH instruments.
